KRYSNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Krystal Biotech, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 3, 2026
$320.25+3.67 (+1.16%)
Close on Oct 19, 2026
- Market cap
- $9.82B
- P/E (TTM)
- 40.1
- Dividend yield
- –
Krystal Biotech statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Biological Products, (No Diagnostic Substances) companies for comparison
Valuation
| Measure | Krystal Biotech | Industry median |
|---|---|---|
| Market Cap | $9.48B | $166.30M |
| Enterprise Value | $8.63B | $87.12M |
| PE Ratio | 40.13 | 19.67 |
| PS Ratio | 21.52 | 3.60 |
| PB Ratio | 6.97 | 2.03 |
| P/TBV Ratio | 6.97 | 2.31 |
| P/FCF Ratio | 36.77 | 17.44 |
| P/OCF Ratio | 34.81 | 13.32 |
Enterprise value
| Measure | Krystal Biotech | Industry median |
|---|---|---|
| EV / Sales | 19.60 | 2.43 |
| EV / EBITDA | 43.66 | 14.69 |
| EV / EBIT | 43.66 | 18.47 |
| EV / FCF | 33.49 | 20.97 |
Income (trailing twelve months)
| Measure | Krystal Biotech | Industry median |
|---|---|---|
| Revenue | $440.48M | $57.94M |
| Operating Income | $197.75M | -$21.49M |
| Pretax Income | $226.62M | -$14.72M |
| Net Income | $241.47M | -$22.46M |
| EBITDA | $197.75M | -$17.14M |
| EPS (Diluted) | $7.98 | -$0.83 |
Margins
| Measure | Krystal Biotech | Industry median |
|---|---|---|
| Operating Margin | 44.9% | -44.5% |
| Pretax Margin | 51.4% | -13.0% |
| Profit Margin | 54.8% | -39.2% |
| EBITDA Margin | 44.9% | -31.3% |
| FCF Margin | 58.5% | -8.85% |
Returns
| Measure | Krystal Biotech | Industry median |
|---|---|---|
| Return on Equity (ROE) | 20.1% | -53.2% |
| Return on Assets (ROA) | 18.3% | -41.0% |
| Return on Invested Capital (ROIC) | 45.3% | -32.2% |
| Return on Capital Employed (ROCE) | 14.4% | -38.0% |
Growth
| Measure | Krystal Biotech | Industry median |
|---|---|---|
| Revenue Growth (YoY) | 22.6% | 6.01% |
| Net Income Growth (YoY) | 64.6% | -37.7% |
| EPS Growth (YoY) | 62.2% | -29.2% |
| FCF Growth (YoY) | 39.0% | 2.34% |
Balance sheet
| Measure | Krystal Biotech | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $845.60M | $62.64M |
| Net Cash (Debt) | $845.60M | $15.77M |
| Net Cash Per Share | $28.57 | $0.66 |
| Equity (Book Value) | $1.36B | $48.61M |
| Book Value Per Share | $45.92 | $1.36 |
| Tangible Book Value | $1.36B | $23.01M |
| Working Capital | $932.25M | $75.09M |
Financial position
| Measure | Krystal Biotech | Industry median |
|---|---|---|
| Current Ratio | 8.32 | 3.30 |
| Quick Ratio | 7.73 | 2.39 |
Cash flow (trailing twelve months)
| Measure | Krystal Biotech | Industry median |
|---|---|---|
| Operating Cash Flow | $272.34M | -$12.39M |
| Capital Expenditures | -$14.56M | -$1.07M |
| Free Cash Flow | $257.78M | -$20.34M |
| FCF Per Share | $8.71 | -$0.42 |
Efficiency
| Measure | Krystal Biotech | Industry median |
|---|---|---|
| Asset Turnover | 0.33 | 0.38 |
| Revenue Per Employee | $1.49M | $398.96K |
| Profits Per Employee | $818.53K | -$705.27K |
| Employee Count | 295 | 74 |
Dividends and yields
| Measure | Krystal Biotech | Industry median |
|---|---|---|
| Earnings Yield | 2.55% | -22.8% |
| FCF Yield | 2.72% | -9.02% |
Shares
| Measure | Krystal Biotech | Industry median |
|---|---|---|
| Shares Outstanding | 29,598,800 | 58,139,000 |
| Shares Change (YoY) | 1.54% | 11.1% |
| Shares Change (QoQ) | 0.54% | 0.54% |
| Float | 24,502,500 | 49,154,900 |
| Shares Held by Insiders | 17.2% | 11.6% |
| Shares Held by Institutions | 102.4% | 59.4% |
Taxes
| Measure | Krystal Biotech | Industry median |
|---|---|---|
| Income Tax | -$14.85M | $89.00K |
| Effective Tax Rate | -6.55% | 20.5% |
Scores
| Measure | Krystal Biotech | Industry median |
|---|---|---|
| Graham Number | $90.80 | $17.04 |
| Graham Upside | -71.6% | -44.3% |
| Altman Z-Score | 41.79 | -0.27 |
| Piotroski F-Score | 6 | 4 |
Calculated by StockData from Krystal Biotech's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.